Butlig, Mary Jean .
HRN: 17-09-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2023
CEFTAZIDIME 1GM (VIAL)
10/27/2023
11/03/2023
IV
1g
Q8
CAP-MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes